http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
진행성 위암환자에 대한 Epirubicin , Cisplatin , 경구 UFT 및 Leucovorin 복합항암화학요법의 효과
김열홍(Yeul Hong Kim),전훈재(Hoon Jai Chun),현진해(Jin Hai Hyun),윤소영(So Young Yoon),서재홍(Jae Hong Seo),최철원(Chul Won Choi),김병수(Byung Soo Kim),목영재(Young Jae Mok),김종석(Chong Suk Kim),김준석(Jun Suk Kim) 대한내과학회 1999 대한내과학회지 Vol.56 No.6
Objective : UFT plus leucovorin treatment had favorable activity and tolerable toxicity in patients with advanced stomach cancer. Recently, high response rates have been reported in patients with advanced stomach cancer with a schedule of epirubicin, cisplatin, and protracted infusion of 5-fluorouracil (5-FU). The advantage of long term oral administration of UFT is that this treatment might be used to mimic protracted infusions of 5-FU. Instead of inconvenience of infusion pump and intravenous catheter for protracted infusion of 5-FU, we administered UFT plus leucovorin in this treatment. Methods : Thirty-seven patients with locally advanced or metastatic stomach cancer received epirubicin, cisplatin, oral UFT plus leucovorin. Epirubicin 50 mg/m2 and cisplatin 60 mg/m2 were administered on day 1 by intravenous injection. UFT 360 mg/m2/day in conjunction with leucovorin administered at 25 mg/m2/day per os in divided daily doses for 21 days followed by a 7-day rest period. Courses were repeated every 4 weeks. The median age of the patients was 55 years with a median World Health Organization (WHO) performance status of 1. Patients received a median of four courses of treatment (range, 2 to 10). Results : Among 37 evaluable patients, two patients achieved complete response, and eighteen had partial responses, for an overall response rate of 54% (95% confidence interval; 39% to 70%). Stable disease was reported in 12 patients (32.5%) and another 5 (13.5%) showed disease progression. The median duration of survival was 10 months (range, 2 to 15+). The main toxicity was nausea/vomiting, leukopenia, diarrhea and oral mucositis. Significant toxicity (WHO grade 3 or 4) included leukopenia in fourteen patients (39.8%), nausea/ vomiting in eleven (29.7%), oral mucositis in five (13.5%), and diarrhea in four (10.8%) patients. Conclusion : We conclude that epirubicin, cisplatin, oral UFT plus leucovorin, a convenient out-patient regimen, has a significant activity in patients with stomach cancer and has tolerable toxicities.
포스터 발표 : 담도,췌장 ; 췌장암에서의 Clusterin 발현과 세포사멸에 관한 연구
김진용 ( Jin Yong Kim ),이홍식 ( Hong Sik Lee ),김영선 ( Young Sun Kim ),전훈재 ( Hoon Jae Jun ),엄순호 ( Soon Ho Um ),이상우 ( Sang Woo Lee ),최재현 ( Jae Hyun Choi ),김창덕 ( Chang Duck Kim ),류호상 ( Ho Sang Ryu ),현진해 ( Jin 대한소화기학회 2002 대한소화기학회 춘계학술대회 Vol.2002 No.-
〈목적〉 췌장암은 조기 진단이 어렵고 항암제치료 및 방사선 치료에 반응도가 매우 낮아 5년 생존율이 약1-3%에 불과할 정도를 치료가 어려운 종양이다. 췌장암이 일반적으로 항암 치료에 반응이 낮은 이유는 아직 규명되고 있지 않으나 췌장암세포가 항암제 및 방사선 치료에 의해 유발되는 세포사멸에 대한 저항력이 큰 것이 가능성으로 제시되고 있다. Clusterin은 세포사멸, 조직재생, 세포 부착등의 여러 가지 생물학적 기능을 갖고 있는 glycoprotei
이상우,이홍식,강동훈,최재현,현진해,전훈재 대한소화기내시경학회 1995 Clinical Endoscopy Vol.15 No.3
Lymphangiomas are made up of multiple lymphatic channels lined by benign-appearing endothelial cells. The lesions can occur anywhere in the body but most commonly affect head, neck and axilla. It rarely involves the gastrointestinal tract and particularly lymphangioma of the colon is very rare. Histologically,it is classified three types as simple or capillary, cavernous, and cystic. We experienced three cases of cavernous lymphangioma of the ascending colon. Case 1, 56-year-old male, had lymphangioma accompanied by ulcerating cancer of the cecum. Case 2, 51-year-old female, had lymphangioma of cecum. Case 3, 41-year-old male had lymphangioma at ileocecal valve. All cases could be diagnosed by colonoscopic snare polypectomy.